Payer Risk & Value
Identify where better targeting or better technology changes outcomes and costs for a covered population.
RISX Science
Better healthcare should not have to cost more.
RISX Science brings scientific, analytic, and operational capability into the space between health plans, providers, and emerging healthcare technologies. We do more than administer workflows or report on data: we help evaluate and operationalize new diagnostic and screening technologies, develop in-silico evidence tools, and use agentic analytics to connect clinical, claims, dental, molecular, imaging, and workflow data. That lets us pinpoint where better technology or better targeting creates real clinical and economic value. Evidence intelligence for better healthcare decisions.
Every figure shown anywhere on this site is computed by the platform’s own engines on synthetic, nonclinical data. Nothing here is a client result, a diagnosis, a coverage decision or a performance claim.
What we do
Three business lines
We work where evidence, operational decisions and emerging technology meet.
Clinical Pathways
Connect screening, diagnosis and treatment decisions to evidence, with the clinician always in control.
Life Sciences & RWE
Build in-silico evidence, target-trial emulators and external comparators that regulators can inspect.
Business line
Dental intelligence
The dental chair is the most underused clinical access point in the plan. Most members see a dentist more reliably than a physician. RISX uses plan data to find the members for whom a dental visit could change a medical outcome, hands the dentist a specific reason to look, and leaves testing and diagnosis with the clinician who owns them.
One shared workflow
Population opportunity, longitudinal data, analytic prioritisation, dental review, confirmatory pathway, and outcome reconciliation — applied across OSA event prevention, cognitive risk and HNSCC early detection.
Start with OSA
The developed line uses the dental encounter to surface members most likely to benefit from obstructive sleep apnea evaluation and treatment.
Demonstration — available on sign-in
A worked obstructive sleep apnea program, on one million synthetic covered lives
RISX maintains a complete worked demonstration of the method: development environment, model training, individualised value policy, review queue, evidence drawers, audit and contract economics. It is computed on synthetic, nonclinical data and is held inside the client workspace rather than published as a public analytic screen.
What the demonstration shows
- Prioritisation by modeled incremental benefit, not by risk score alone.
- An emulated target trial with balance, overlap and sensitivity diagnostics.
- Every result inspectable through five evidence drawers and a replay manifest.
- Clinical, plan-cost and contract ledgers kept separate.
How to see it
Workspace access is granted per person and per role. Sign in with a client account, or ask us for a guided walkthrough.
A second worked demonstration: cancer pathways
The same method is worked through for cancer pathways — a modeled population grounded in public SEER, CMS, USPSTF and NCCN context, a transparent enrichment cascade, a clinician review queue and a full provenance record. It is synthetic and nonclinical, makes no diagnostic, screening-performance or coverage claim, and is held inside the client workspace rather than published as a public analytic screen.
Where to go
Company, capability and the technical record
The left column describes the company and what it does. The right column is the public technical narrative; the operational workspace sits behind client sign-in.
Company
- About RISX ScienceWho we are, how we work, and the standards we hold analytic work to.
- What we doPayer risk and value, clinical pathways, life sciences and RWE, dental intelligence.
- ResourcesPublished material, positions and briefings.
- ContactStart a conversation about a specific decision or population.
Technology and governance
- Platform architectureLayers, engines, workflows and outputs, and what each layer constrains.
- Analytic products and methodsWhat each engine estimates and how its output must be read.
- Security and governanceControls over identity, access and permitted use.
- Client sign inAuthenticated workspace: analytic screens, audits, economics and operations.
How it works
Nothing reaches a decision screen without passing the layer beneath it
RISX Science turns the algorithms developed for each use case into bespoke, governed analytic agents — configured around each client's data, clinical priorities, workflows and economic objectives. Clinical calculation runs server-side; the browser renders results, it never computes them.
Partnership
Work with us
We work with health plans, provider and dental organisations, and life-science teams who need analytic results they can defend line by line.